Debate over 'Right-to-Try' Laws

 - NORBERTO DUARTE/AFP/Getty Images

NORBERTO DUARTE/AFP/Getty Images

Debate over 'Right-to-Try' Laws

Lawmakers in three states have passed so-called "Right-to-Try" laws, which give terminally ill patients access to experimental drugs without FDA approval. Diane and guests discuss the growing demand for these laws and whether they jeopardize patient safety.

Lawmakers in three states have passed so-called "Right-to-Try" laws, which give terminally ill patients access to experimental drugs without FDA approval. Diane and guests discuss the growing demand for these laws and whether they jeopardize patient safety.

Guests

Julie Rovner

senior correspondent, Kaiser Health News; author of "Health Care Policy and Politics A-Z."

Arthur Caplan

director of the division of medical ethics, New York University Langone Medical Center.

Sascha Haverfield

vice president, scientific and regulatory affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)

Lucy Caldwell

communications director, The Goldwater Institute

Dr. Margaret Hamburg

commissioner of the Food and Drug Administration.

Please familiarize yourself with our Code of Conduct and Terms of Use before posting your comments.

Our address has changed!

The Diane Rehm Show is produced by member-supported WAMU 88.5 in Washington DC.